ask="83.00"
ask_size="700"
average_daily_volume="378303"
bid="81.50"
bid_size="300"
book_value="6.84"
change="-2.72"
change_from_200_day_moving_average="19.65"
change_from_50_day_moving_average="4.70"
change_from_52_week_high="-6.27"
change_From_52_week_low="49.18"
change_in_percent="-3.20%"
close="82.20"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="1.54"
ebitda="26.14M"
eps_estimate_current_year="4.59"
eps_estimate_next_quarter="1.95"
eps_estimate_next_year="5.58"
ex_dividend_date="N/A"
float_shares="8082000"
high="85.26"
high_52_weeks="88.47"
last_trade_date="1/5/2017"
last_trade_price="82.20"
last_trade_size="100"
last_trade_time="4:00pm"
low="81.62"
low_52_weeks="33.02"
market_capitalization="1.27B"
moving_average_200_day="62.55"
moving_average_50_day="77.50"
name="Eagle Pharmaceuticals
Inc."
notes="N/A"
one_year_target_price="92.75"
open="85.09"
pe_ratio="53.52"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="+31.42%"
percent_change_from_50_day_moving_average="+6.07%"
percent_change_from_52_week_high="-7.09%"
percent_change_from_52_week_low="+148.94%"
previous_close="84.92"
price_eps_estimate_current_year="17.91"
price_eps_Estimate_next_year="14.73"
price_per_book="12.42"
price_per_sales="10.36"
revenue="126.52M"
shares_outstanding="15435000"
short_ratio="12.13"
stock_exchange="NGM"
symbol="EGRX"
volume="428870"
weeks_range_52="33.02 - 88.47"
